{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:24:50Z","timestamp":1778855090554,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011772","name":"Novartis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ancard.2021.05.004","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T09:06:43Z","timestamp":1626253603000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance"],"prefix":"10.1016","volume":"71","author":[{"given":"P.","family":"Sabouret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Attias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beauvais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bouleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gibault Genty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Galat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Hulot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Logeart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Meune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pezel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Damy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2021.05.004_bib0455","series-title":"Guide parcours de soins insuffisance cardiaque","first-page":"1","author":"HAS","year":"2014"},{"issue":"27","key":"10.1016\/j.ancard.2021.05.004_bib0460","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0465","first-page":"810","article-title":"Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials","volume":"44","author":"McAlister","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ancard.2021.05.004_bib0470","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ejhf.568","article-title":"Heart failure association of the European Society of Cardiology heart failure nurse curriculum","volume":"18","author":"Riley","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.ancard.2021.05.004_bib0475","doi-asserted-by":"crossref","first-page":"e011737","DOI":"10.1161\/JAHA.118.011737","article-title":"Nurse-led heart failure clinics are associated with reduced mortality but not heart failure hospitalization","volume":"8","author":"Savarese","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.ancard.2021.05.004_bib0480","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11936-019-0750-3","article-title":"The impact of pharmacist-based services across the spectrum of outpatient heart failure therapy","volume":"21","author":"West","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"38","key":"10.1016\/j.ancard.2021.05.004_bib0485","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","article-title":"Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF","volume":"36","author":"Jhund","year":"2015","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ancard.2021.05.004_bib0490","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jacc.2015.08.878","article-title":"Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF","volume":"66","author":"Simpson","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.ancard.2021.05.004_bib0500","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0505","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ejhf.1670","article-title":"Initiation of sacubitril\/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study","volume":"22","author":"Senni","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0510","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ancard.2021.05.004_bib0515","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ejhf.1531","article-title":"Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0520","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0525","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jamacardio.2019.1049","article-title":"Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial","volume":"4","author":"Greenberg","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"10254","key":"10.1016\/j.ancard.2021.05.004_bib0530","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"The Lancet"},{"issue":"17","key":"10.1016\/j.ancard.2021.05.004_bib0535","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/heartjnl-2018-314381","article-title":"Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis","volume":"105","author":"Beggs","year":"2019","journal-title":"Heart"},{"issue":"21","key":"10.1016\/j.ancard.2021.05.004_bib0540","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0545","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with sacubitril\/valsartan: the PARADIGM-HF trial","volume":"73","author":"Myhre","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0550","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0555","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1681\/ASN.2018010103","article-title":"Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG OUTCOME trial","volume":"29","author":"Wanner","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0560","doi-asserted-by":"crossref","first-page":"e004769","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769","article-title":"TTR (Transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis","volume":"11","author":"Rosenblum","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0565","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ancard.2021.05.004_bib0570","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.jacc.2018.09.073","article-title":"His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block","volume":"72","author":"Arnold","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ancard.2021.05.004_bib0575","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of his bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ancard.2021.05.004_bib0580","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0585","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0590","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","article-title":"Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction","volume":"11","author":"Agricola","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10.1016\/j.ancard.2021.05.004_bib0595","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ancard.2021.05.004_bib0600","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0605","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ancard.2021.05.004_bib0610","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs. antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ancard.2021.05.004_bib0615","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/TP.0000000000001724","article-title":"Prediction of waitlist mortality in adult heart transplant candidates: the candidate risk score","volume":"101","author":"Jasseron","year":"2017","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0620","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/ajt.15201","article-title":"Optimization of heart allocation: the transplant risk score","volume":"19","author":"Jasseron","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ancard.2021.05.004_bib0625","series-title":"Guide du parcours de soins. Insuffisance cardiaque","first-page":"1","author":"Sant\u00e9 HAd","year":"2014"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0630","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hrtlng.2009.07.008","article-title":"Qualitative examination of compliance in heart failure patients in The Netherlands","volume":"39","author":"van der Wal","year":"2010","journal-title":"Heart Lung"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0635","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijcard.2012.09.030","article-title":"Therapeutic patient education and all-cause mortality in patients with chronic heart failure: a propensity analysis","volume":"168","author":"Juilliere","year":"2013","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.ancard.2021.05.004_bib0640","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/heartjnl-2013-304852","article-title":"Determinants of effective heart failure self-care: a systematic review of patients\u2019 and caregivers\u2019 perceptions","volume":"100","author":"Clark","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ancard.2021.05.004_bib0645","first-page":"22","article-title":"Consultation d\u2019annonce dans l\u2019insuffisance cardiaque\u202f: quelle place\u202f? Patient's information and diagnosis announcement in heart failure","volume":"287","author":"Berthelot","year":"2020","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0650","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.0000151811.53450.B8","article-title":"Discharge education improves clinical outcomes in patients with chronic heart failure","volume":"111","author":"Koelling","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0655","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/chf.12031","article-title":"Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure","volume":"19","author":"Basoor","year":"2013","journal-title":"Congest Heart Fail"},{"issue":"8\u20139","key":"10.1016\/j.ancard.2021.05.004_bib0660","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.acvd.2019.05.003","article-title":"Improving quality of care in patients with decompensated acute heart failure using a discharge checklist","volume":"112","author":"Legallois","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ancard.2021.05.004_bib0665","unstructured":"Target: HF Strategies and Clinical Tools [Available from: http:\/\/www.heart.org\/en\/professional\/quality-improvement\/target-heart-failure\/strategies-and-clinical-tools (Last Reviewed: Jun 13, 2018); American Heart Association."},{"key":"10.1016\/j.ancard.2021.05.004_bib0670","unstructured":"(SFC) SFdC. Check-list de sortie [Available from: https:\/\/www.medecin.giccardio.fr\/index.php\/fr\/outils\/check-list-de-sortie."},{"issue":"24","key":"10.1016\/j.ancard.2021.05.004_bib0675","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0680","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.acvd.2016.05.009","article-title":"Patient journey in decompensated heart failure: an analysis in departments of cardiology and geriatrics in the Greater Paris University Hospitals","volume":"110","author":"Laveau","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0685","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0690","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ejhf.887","article-title":"Physicians\u2019 guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0695","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.acvd.2013.08.002","article-title":"First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up","volume":"106","author":"Tuppin","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"issue":"01","key":"10.1016\/j.ancard.2021.05.004_bib0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2375-4273.1000221","article-title":"Medical inertia in the optimization of heart failure treatment after discharge and its relationship to outcome","volume":"06","author":"E","year":"2018","journal-title":"Health Care Curr Rev"},{"key":"10.1016\/j.ancard.2021.05.004_bib0705","series-title":"Am\u00e9liorer la qualit\u00e9 du syst\u00e8me de sant\u00e9 et ma\u00eetriser les d\u00e9penses. Propositions de l\u2019Assurance maladie pour 2020","first-page":"1","author":"CNAM","year":"2019"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0710","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-terminal Pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0715","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ejhf.699","article-title":"Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study","volume":"19","author":"Plichart","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0720","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"17","key":"10.1016\/j.ancard.2021.05.004_bib0725","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week","volume":"74","author":"Aimo","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ancard.2021.05.004_bib0730","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/1354750X.2017.1319421","article-title":"The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure","volume":"22","author":"Mir\u00f3","year":"2017","journal-title":"Biomarkers"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0735","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0740","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11886-020-01288-z","article-title":"Soluble ST2 and soluble markers of fibrosis: emerging roles for prognosis and guiding therapy","volume":"22","author":"Sharim","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ancard.2021.05.004_bib0745","series-title":"NICE guidelines","year":"2018"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0750","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13643-018-0776-8","article-title":"B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data","volume":"7","author":"Pufulete","year":"2018","journal-title":"Syst Rev"},{"issue":"14","key":"10.1016\/j.ancard.2021.05.004_bib0755","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O\u2019Connor","year":"2009","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.ancard.2021.05.004_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23250","article-title":"Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis","volume":"23","author":"Taylor","year":"2019","journal-title":"Health Technol Assess"},{"issue":"8","key":"10.1016\/j.ancard.2021.05.004_bib0765","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jchf.2019.04.023","article-title":"Exercise-based rehabilitation for heart failure: cochrane systematic review, meta-analysis, and trial sequential analysis","volume":"7","author":"Taylor","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0770","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.acvd.2019.07.003","article-title":"Physical activity for patients with heart failure: Position paper from the heart failure (GICC) and cardiac rehabilitation (GERS-P) Working Groups of the French Society of Cardiology","volume":"112","author":"Zores","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ancard.2021.05.004_bib0775","first-page":"Cd007130","article-title":"Home-based versus centre-based cardiac rehabilitation","volume":"6","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0780","doi-asserted-by":"crossref","first-page":"e9629","DOI":"10.1097\/MD.0000000000009629","article-title":"Home-based cardiac rehabilitation improves quality of life, aerobic capacity, and readmission rates in patients with chronic heart failure","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"10152","key":"10.1016\/j.ancard.2021.05.004_bib0785","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(18)31880-4","article-title":"Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial","volume":"392","author":"Koehler","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ancard.2021.05.004_bib0790","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M14-0083","article-title":"Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis","volume":"160","author":"Feltner","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ancard.2021.05.004_bib0795","series-title":"Prado, pionnier du parcours de soins coordonn\u00e9 du patient","first-page":"1","author":"Ameli","year":"2019"},{"issue":"10166","key":"10.1016\/j.ancard.2021.05.004_bib0800","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ancard.2021.05.004_bib0805","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0810","first-page":"326","article-title":"Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study","volume":"38","author":"Mohseni","year":"2017","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0815","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.118.036788","article-title":"Influenza vaccine in heart failure","volume":"139","author":"Modin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2021.05.004_bib0820","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The prevalence of frailty in heart failure: a systematic review and meta-analysis","volume":"236","author":"Denfeld","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ancard.2021.05.004_bib0825","first-page":"8739058","article-title":"Prognostic value of frailty for older patients with heart failure: a systematic review and meta-analysis of prospective studies","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0830","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCHEARTFAILURE.109.865022","article-title":"Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure","volume":"3","author":"Pilotto","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1474515117708888","article-title":"Frailty assessment instruments in heart failure: a systematic review","volume":"17","author":"McDonagh","year":"2018","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"18","key":"10.1016\/j.ancard.2021.05.004_bib0840","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199511023331806","article-title":"A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure","volume":"333","author":"Rich","year":"1995","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ancard.2021.05.004_bib0845","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ancard.2021.05.004_bib0850","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ancard.2021.05.004_bib0855","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory\u00a0\u2013\u00a0a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"10.1016\/j.ancard.2021.05.004_bib0860","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ancard.2021.05.004_bib0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.116.003588","article-title":"Renin-Angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data","volume":"10","author":"Beldhuis","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0870","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MAJ.0000000000000475","article-title":"Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease","volume":"349","author":"Shirazian","year":"2015","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.ancard.2021.05.004_bib0875","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ageing\/29.6.489","article-title":"Inappropriate use of loop diuretics in elderly patients","volume":"29","author":"Kelly","year":"2000","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.ancard.2021.05.004_bib0880","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","article-title":"Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0885","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejhf.13","article-title":"Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction","volume":"16","author":"Clark","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.ancard.2021.05.004_bib0890","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.acvd.2020.03.018","article-title":"Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology","volume":"113","author":"Mewton","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.ancard.2021.05.004_bib0895","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/eurjhf\/hfs085","article-title":"Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure","volume":"14","author":"Damy","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ancard.2021.05.004_bib0900","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15420\/CFR.2015.01.01.16","article-title":"Sleep-disordered breathing in heart failure\u00a0\u2013\u00a0Current state of the art","volume":"1","author":"Cowie","year":"2015","journal-title":"Card Fail Rev"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392821000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392821000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:25:00Z","timestamp":1762086300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392821000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0003392821000688"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2021.05.004","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2021.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}